78
Management
4.2.8.10. Adults With Cancer or History of Cancer
COR LOE
Recommendations
1 B-NR
1. Adult cancer survivors with life expectancy of at least 2 years
who otherwise qualify for LLT should be treated similarly
to people without history of cancer to reduce the risk of
ASCVD events.
1 B-NR
2. In adults with active cancer currently on statin therapy,
treatment should be continued to reduce ASCVD risk
unless there is concern for a specific drug interaction or life
expectancy is <1 year.
2b B-R
3. In adults with active cancer, initiation of statin therapy may be
considered to prevent anthracycline-induced cardiotoxicity.
